influx pathway in lymphocytes and is essential for T cell function and adaptive immunity. SOCE is mediated by Ca 2+ release-activated Ca 2+ (CRAC) channels that are activated by stromal interaction molecule (STIM) 1 and STIM2. SOCE regulates many Ca 2+ -dependent signaling molecules, including calcineurin, and inhibition of SOCE or calcineurin impairs antigen-dependent T cell proliferation. We here report that SOCE and calcineurin regulate cell cycle entry of quiescent T cells by controlling glycolysis and oxidative phosphorylation. SOCE directs the metabolic reprogramming of naive T cells by regulating the expression of glucose transporters, glycolytic enzymes, and metabolic regulators through the activation of nuclear factor of activated T cells (NFAT) and the PI3K-AKT kinase-mTOR nutrientsensing pathway. We propose that SOCE controls a critical ''metabolic checkpoint'' at which T cells assess adequate nutrient supply to support clonal expansion and adaptive immune responses.
In Brief
Clonal expansion of T cells is critical for protective immunity. Vaeth et al. (2017) demonstrate that store-operated calcium entry (SOCE), calcineurin, and NFAT control cell-cycle entry and proliferation of activated T cells through upregulation of glycolysis and oxidative phosphorylation. -binding protein calmodulin (M€ uller and Rao, 2010) . In T cells, Ca 2+ release-activated Ca 2+ (CRAC) channels are the main source of [Ca 2+ ] i upon TCR ligation and are critical for calcineurin activation (Feske et al., 2012) . CRAC channels are located in the plasma membrane and in T cells are composed of ORAI1 and ORAI2 proteins that form the Ca 2+ -permeant pore of the channel Prakriya et al., 2006; Vaeth et al., 2017) . CRAC channels are activated upon TCR stimulation, which triggers the production of the second messenger inositol 1,4,5-trisphosphate (IP 3 ) and the opening of IP 3 receptor channels in the endoplasmic reticulum (ER) (Feske, 2007) . The subsequent decrease in the ER Ca 2+ concentration results in the dissociation of Ca 2+ from stromal interaction molecule (STIM) 1 and STIM2, which are located in the membrane of the ER. In the Ca 2+ -free state, STIM1 and STIM2 bind to and activate CRAC channels in the plasma membrane. The resulting Ca 2+ influx is called store-operated Ca 2+ entry (SOCE) as it is regulated by the Ca 2+ concentration within the ER (Feske, 2007; Feske et al., 2012) . Patients with null mutations in ORAI1 or STIM1 suffer from severe immunodeficiency as part of a complex CRAC channelopathy syndrome (Lacruz and Feske, 2015) . As a consequence of abolished SOCE, the patients' T cells fail to activate calcineurin, which results in impairments in both proliferation and cytokine production (Feske et al., 2012) . Similar to those in SOCE-deficient patients, lymphocytes from mice with deletion of Orai1 and Orai2 or Stim1 and Stim2 genes in T cells have impaired cytokine production and antigen-dependent proliferation that result in defective T-cell-mediated immune responses (Desvignes et al., 2015; Oh-Hora et al., 2008; Shaw et al., 2014; Vaeth et al., 2016; Vaeth et al., 2017) . Many of the effects of SOCE and calcineurin signaling on T cell function are mediated by transcription factors of the nuclear factor of activated T cells (NFAT) family (Feske, 2007; M€ uller and Rao, 2010) . Of the four Ca 2+ -regulated NFAT family members, NFATc1 (or NFAT2), NFATc2 (NFAT1), and NFATc3 (NFAT4) are functional in T cells (M€ uller and Rao, 2010) . Calcineurin dephosphorylates serine and threonine residues within the NFAT regulatory domains, resulting in nuclear translocation and transcriptional activation (M€ uller and Rao, 2010).
The mechanisms by which SOCE, calcineurin, and NFAT control proliferation of T cells remain poorly defined. Some of the proposed mechanisms involve regulation of the ''growth factor'' interleukin-2 (IL-2) and cyclins or cyclin-dependent kinases, which in some cell types depend on calcineurin and NFAT signaling (Mognol et al., 2016) . Although IL-2 promotes T cell proliferation in vitro in an autocrine or paracrine fashion, addition of exogenous IL-2 to T cells from patients with null mutations in ORAI1 or STIM1 or to T cells from Orai1 fl/fl Cd4Cre Orai2 À/À mice only weakly rescues TCR-induced proliferation in vitro (Feske et al., 1996; Fuchs et al., 2012; Le Deist et al., 1995; Picard et al., 2009; Schaballie et al., 2015; Vaeth et al., 2017) . Another possible mechanism by which SOCE might control T cell proliferation is through the regulation of metabolism. Naive T cells are metabolically quiescent and have low rates of nutrient uptake, glycolysis, and biosynthesis. Upon TCR stimulation, T cells undergo a ''glycolytic switch'' from low-rate catabolic to high-rate anabolic metabolism. This 'switch' provides the glycolytic intermediates required for cell growth and division (Pearce et al., 2013) . The main source of carbohydrates in activated T cells is glucose, and depriving T cells of glucose or deleting glucose transporter 1 (GLUT1) impairs TCR-induced proliferation and T-cell-mediated immunity (Macintyre et al., 2014) . Several signaling pathways and transcription factors have been reported to regulate the metabolic adaptation of T cells after their activation (Buck et al., 2015) , but the role of SOCE and calcineurin in T cell metabolism in general and in aerobic glycolysis in particular is unknown. We here report that SOCE and calcineurin control T cell proliferation by regulating the metabolic reprogramming of quiescent T cells after TCR stimulation. Abolishing SOCE in mouse T cells by conditional deletion of Stim1 and Stim2 or calcineurin inhibition impaired TCR-induced proliferation in vitro and clonal expansion of virus-specific T cells in vivo. SOCE and calcineurin controlled the expression of GLUT1 and GLUT3, glycolytic enzymes and proteins required for mitochondrial respiration. In addition, we found that c-Myc, IRF4, HIF1a, and other transcription factors that regulate the glycolytic program of activated T cells were induced in an SOCE-and calcineurin-dependent manner. The metabolic effects of SOCE were mediated by NFAT-regulated transcription and the PI3K-AKT kinase-mTOR nutrient-sensing pathway. We found that NFAT bound to several glycolysis-regulating genes. Deletion of NFATc1 and NFATc2 in T cells strongly impaired glycolytic gene expression, whereas expression of constitutively active NFATc1 in SOCE-deficient T cells restored glycolysis and T cell proliferation in vivo. We conclude that SOCE orchestrates the metabolic reprogramming of naive T cells, thus facilitating cell growth, cell cycle entry, and T cell proliferation. Our study provides mechanistic insights into the potent immunosuppressive effects of calcineurin inhibitors.
RESULTS

Calcineurin Signaling and SOCE Control Proliferation and Cell-Cycle Entry of T Cells
To investigate how SOCE regulates antigen-dependent proliferation of T cells in vivo, we used wild-type (WT) and Stim1
Cd4cre mice (whose T cells lack SOCE) that were crossed to SMARTA transgenic mice expressing a MHC-class-II-restricted transgenic TCRs specific for the GP 61-80 epitope of lymphocytic choriomeningitis virus (LCMV). We adoptively transferred CD4 + T cells into congenic WT mice that were infected with LCMV ( Figure 1A ). 8 days after infection, we found significantly reduced expansion of Stim1
Cd4cre SMARTA T cells in the spleen of these mice compared to WT controls ( Figure 1B ). Defective proliferation was not due to impaired activation of SOCE-deficient T cells, as indicated by the fact that expression of the activation marker CD44 was comparable to that in WT T cells ( Figure 1C ). Given that WT host mice provide an immunocompetent milieu, impaired expansion of SOCE-deficient T cells must be due to a T-cell-intrinsic role of SOCE in proliferation. A similar proliferation defect of CD4 + T cells from
Cd4cre mice was observed after T cell stimulation in vitro ( Figure 1E ), despite normal CD44 expression ( Figure 1D ). Proliferation was also abolished in WT T cells treated with the calcineurin inhibitor FK506 ( Figure 1E ), suggesting that SOCE acts through calcineurin. Neither SOCE-deficient T cells nor FK506-treated WT T cells entered the cell cycle, as indicated by the fact that they failed to upregulate the cell-cycle marker Ki-67 after TCR stimulation ( Figure 1F ). Ki-67 is detected in all phases of the cell cycle except G 0 (marking quiescent cells), demonstrating that SOCE and calcineurin regulate cell-cycle entry and proliferation of T cells.
SOCE and Calcineurin Induce the Metabolic Switch of Activated T Cells
In order to progress through G 1 and commit to mitosis and proliferation, cells have to pass a metabolic checkpoint that tests nutrient sufficiency (Foster et al., 2010) . Aerobic glycolysis is the main source of anabolic metabolites after TCR stimulation (Buck et al., 2015) . 2-deoxy-D-glucose (2-DG), which suppresses glycolysis, prevented Ki-67 expression in WT T cells (Figure 2A ), confirming that glucose utilization is essential for cell-cycle commitment and T cell proliferation. To test whether SOCE and calcineurin signaling are required for the metabolic switch of T cells, we analyzed aerobic glycolysis and oxidative phosphorylation (OXPHOS) in quiescent and activated T cells. T cells from WT and Stim1
Cd4cre mice were stimulated in the presence or absence of FK506 and analyzed for their oxygen consumption rate (OCR) as a measure of OXPHOS and for their extracellular acidification rate (ECAR), which correlates with lactate production. In comparison to non-stimulated cells, activated WT T cells showed a marked increase in basal OCR; this increase was largely blocked by FK506 ( Figures 2B and 2C ). Compared to non-stimulated cells, activated WT cells also showed increased maximal mitochondrial respiration after treatment with carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) (Figures 2B and 2D ). This activation-induced increase in OCR was dependent on SOCE and calcineurin, as shown by the fact that it was almost completely abolished in SOCE-deficient T cells and in T cells treated with FK506 ( Figures  2B and 2D) . Furthermore, stimulation induced a drastic increase in basal ECAR in WT T cells, but this increase was severely impaired in SOCE-deficient and FK506-treated T cells (Figures 2E and 2F) . Combined analysis of the respiratory capacity and glycolytic function of stimulated T cells clearly separated WT from SOCE-deficient and FK506-treated cells, which were similar to resting cells ( Figure 2G ). Thus, in the absence of SOCE or (legend continued on next page) calcineurin function, stimulated T cells remain in a quiescent metabolic state similar to that of naive T cells. The metabolic switch of T cells is required for the promotion of anabolic metabolism and biosynthesis of nucleotides, fatty acids, and amino acids to support cell growth (Pearce et al., 2013) . Whereas stimulated WT T cells showed a strong increase in cell size ( Figure 2H ) and protein content ( Figure 2I ), no such increase was observed in SOCE-deficient or FK506-treated T cells ( Figures 2H and 2I ). IL-2 is an autocrine or paracrine ''growth factor'' that promotes T cell proliferation, and inhibition of SOCE or calcineurin blocks IL-2 production by T cells (Oh-Hora et al., 2008) . We tested whether abolished proliferation and metabolic switching of SOCE-deficient T cells were due to impaired IL-2 production. The addition of exogenous IL-2 only marginally restored proliferation of T cells from Stim1
Cd4cre mice in vitro ( Figure S1A ). Likewise, IL-2 did not rescue basal or maximal OCR of SOCE-deficient T cells ( Figure S1B-D) , and it failed to restore their impaired glycolysis (Figures S1E and S1F). Thus, despite IL-2 addition, SOCE-deficient T cells remained in a low metabolic state ( Figure S1G ), indicating that their impaired metabolic switch and proliferation were not due to reduced IL-2 production. Collectively, these findings demonstrate that SOCE and calcineurin control the metabolic switch of T cells as a prerequisite for cell-cycle entry.
SOCE and Calcineurin Regulate Aerobic Glycolysis in T Cells
To investigate how SOCE and calcineurin control T cell metabolism, we performed polar-metabolite profiling by liquid chromatography followed by mass spectrometry of WT and SOCEdeficient T cells ( Figure 2J ) in an attempt to capture the majority of glycolytic and TCA-cycle intermediates ( Figure S2A ). In stimulated WT T cells, the levels of glycolytic metabolites increased up to 300-fold in comparison to levels in unstimulated cells ( Figure 2J and Figure S2B ). Similar changes were observed in the TCA cycle; the amounts of TCA cycle intermediates were also markedly increased after stimulation of WT T cells ( Figure 2J and Figure S2B ). In addition, we found a greater abundance of pentose phosphate pathway metabolites, which are crucial for nucleotide synthesis in stimulated T cells ( Figure 2J and Figure S2D ), and non-essential amino acids ( Figure 2K and Figure S3 ). In sharp contrast, stimulation of SOCE-deficient T cells and FK506-treated WT T cells resulted in a strongly attenuated increase in the amounts of polar metabolites ( Figure 2J and Figures S2 and S3 ), including the most upstream glycolysis product, glucose 6-phosphate. Consequently, the abundance of nucleotides and various amino acids was strongly reduced in SOCE-or calcineurin-deficient T cells (Figures 2J and 2K and Figures S2 and S3) . These findings suggest that SOCE controls aerobic glycolysis through glucose utilization.
SOCE and Calcineurin Regulate Glucose Uptake and GLUT1 and GLUT3 Expression Given the blunted increase in the amount of glucose-6-phosphate in stimulated T cells from Stim1
Cd4cre mice, we hypothesized that SOCE might control glucose uptake. When we measured glucose utilization of T cells from the medium after TCR stimulation, we observed that stimulated WT T cells used $4 times more glucose than quiescent T cells ( Figure S4A ). By contrast, SOCE-deficient or FK506-treated WT T cells did not show significantly increased glucose utilization ( Figure S4A ). Direct measurements of glucose uptake in WT CD4 + and CD8 + T cells showed 2.5-fold and $3.3-fold increases, respectively, in the uptake of the fluorescent glucose analog 2-NBDG after TCR stimulation. This increase was almost absent in both SOCE-deficient and FK506-treated T cells ( Figures 3A and 3B ). We observed a similar defect in glucose uptake when we measured intracellular tritiated glucose counts ( Figure S4B ). GLUT1 is important for glucose uptake by activated CD4 + T cells, and its expression is strongly induced upon TCR stimulation (Macintyre et al., 2014) . We confirmed that GLUT1 (murine gene name Slc2a1) is highly expressed in activated WT T cells ( Figures S4C and S4F ). In addition, activated WT T cells also showed robust transcription of GLUT3 (Slc2a3) ( Figures S4C  and S4F ), although Slc2a3 mRNA concentrations peaked later than those of Slc2a1 ( Figure S4F ). GLUT1 and GLUT3 protein expression was robustly induced in stimulated WT CD4 + ( Figure 3C and 3E) and WT CD8 + T cells ( Figure 3D and 3F). No such increase was observed in SOCE-deficient or FK506-treated WT CD4 + T cells ( Figure 3C and 3E). In CD8 + T cells, the lack of SOCE partially impaired GLUT1 and GLUT3 protein expression ( Figures 3D and 3F ). This finding was consistent with more prominent defects in glucose uptake and cell growth in SOCE-deficient CD4 + T cells than in CD8 + T cells (Figures 3A and B and Figures 3G and H) . Taken together, our data demonstrate that SOCE controls the induction of GLUT1 and GLUT3, glucose uptake, and anabolic growth of T cells.
SOCE Controls Expression of Glycolytic and Mitochondrial Enzymes in T Cells
We next investigated whether SOCE regulates glycolysis by mechanisms other than glucose uptake. Stimulation of WT T cells caused pronounced upregulation of not only Slc2a1 and Slc2a3, but also several glycolytic enzymes, including hexokinase 2 (Hk2), aldolase A (Aldoa), phosphoglycerate kinase 1 (Pgk1), and enolase 1 (Eno1) (Figures 4A and 4B) . This induction was completely abolished in SOCE-deficient T cells and T cells treated with FK506 ( Figure 4B ). The transcription of many of these enzymes is controlled by metabolic ''master regulators'' such as c-Myc, HIF-1a, and IRF4 (Buck et al., 2015; Man et 2013; Wang et al., 2011) . We found that upon TCR stimulation, transcripts of Myc, Irf4, and Hif1a were strongly induced in WT T cells but not in SOCE-deficient or FK506-treated T cells ( Figure 5C ). To understand the temporal relationship between the expression of metabolic regulators, glucose transporters, and glycolytic enzymes, we quantified their transcripts over a period of 72 hr after stimulation . Myc and Irf4 were rapidly induced in a SOCE-dependent manner ( Figure S4D ), whereas Slc2a1, Slc2a3 ( Figure S4E ), Hk2, Aldoa, and Pgk1
( Figure S4F ) showed a delayed induction, consistent with the possibility that SOCE regulates glucose transporter and glycolytic gene expression through Myc and Irf4 induction. Because T cell stimulation also enhanced mitochondrial respiration, which was impaired in the absence of SOCE (Figure 2 FK506: Figure 4D ). In contrast, mitochondrial numbers increased to a similar degree in WT and SOCE-deficient T cells upon stimulation ( Figure 4E ). We next analyzed mitochondrial electron transport chain (ETC) complexes. TCR stimulation increased the expression of components of all five ETC complexes in WT T cells, whereas the expression of complexes I, II, and IV was strongly impaired in T cells of Stim1 fl/fl Stim2 fl/fl Cd4cre mice and in WT T cells treated with FK506 ( Figures 4F and 4G ). This defect correlated with blunted ATP production by SOCE-deficient and FK506-treated WT T cells ( Figure 4H ). Expression of mitochondrial ETC complexes is regulated by the PGC-1 family of transcriptional co-regulators, which includes PGC-1a, PGC1b, and PPRC1 (Scarpulla, 2011) . Although we detected no Ppargc1a (PGC-1a) mRNA expression in WT T cells and only low amounts of Ppargc1b (PGC-1b) mRNA ( Figure S4H ), we observed robust induction of Pprc1 (PPRC1) upon stimulation ( Figure 4I and Figure S4H ) and found that this induction was dependent on SOCE and calcineurin ( Figure 4I ). Our data show that SOCE and calcineurin regulate the metabolic reprogramming of T cells by controlling the expression of genes required for aerobic glycolysis and mitochondrial respiration.
FK506 (
SOCE and Calcineurin Control Metabolic Reprogramming of T Cells through NFAT
To understand how SOCE and calcineurin control the metabolic reprogramming of T cells, we analyzed the transcriptional regulation of glucose transporters, glycolytic enzymes, and regulators of glycolysis, the expression of which we had found to be SOCE and calcineurin dependent. In silico analyses of common transcription factor binding motifs revealed the presence of consensus NFAT binding motifs in the regulatory regions of Slc2a1, Slc2a3, Hk2, Aldoa, Pgk1, and Eno1, as well as Myc, Irf4, and Hif1a. Analysis of DNase I hypersensitivity (Bevington et al., 2016) and ATAC-sequencing (Mognol et al., 2017) Figure 5A and Figure S5A ). Previously, NFAT had been shown to regulate Myc expression through a proximal promoter element (Mognol et al., 2016) ; however, we did not observe strong NFAT binding within the Myc proximal promoter in CD8 + T cells ( Figure S5A ). We further analyzed the binding of NFAT to the regulatory regions of Slc2a1, Slc2a3, and various glycolytic genes to determine whether SOCE regulates the expression of these genes directly through NFAT. Most of these genes, including Slc2a1, showed no or only weak NFAT binding ( Figure S5A and data not shown), suggesting that they are not directly regulated by NFAT. However, both NFATc1 and NFATc2 bound to an intronic region of the Hk2 gene and to the promoter as well as a putative upstream regulatory element (-16 kb) in Slc2a3 ( Figure 5A and Figure S5A ). We tested the ability of the Hk2 intronic element, the Slc2a3 promoter, and the Slc2a3 -16 kb upstream regulatory element to transactivate luciferase reporter gene (Luc) expression in vitro ( Figure 5B ). The activity of the Slc2a3 promoter was induced by stimulation and was sensitive to CsA. Similar results were obtained with the Slc2a3 -16 kb upstream regulatory element when placed upstream of the Slc2a3 promoter (Figure 5B Figure S5A ) and other genes that showed NFATc1 and NFATc2 binding to their regulatory regions was strongly impaired, whereas expression of genes with no or only weak NFAT binding, including Myc and Slc2a1, was less affected by the loss of NFATc1 and NFATc2 ( Figure S5B ). It is noteworthy that FK506 treatment further suppressed the induction of all NFATc1-and NFATc2-dependent genes ( Figure 5C and Figure S5B ), which could be due to the presence of NFATc3 in T cells, NFAT-independent effects of FK506 (Dutta et al., 2017; Frischbutter et al., 2011) , or inhibition of the PI3K-AKT-mTOR pathway as shown further below ( Figures 6A-6D ). By contrast, T cells expressing caNFATc1 had significantly increased expression (uninhibitable by FK506) of Irf4, Hif1a, Slc2a1, Slc2a3, and Hk2 after stimulation in comparison to WT T cells, which indicated that expression of these genes is regulated by NFATc1 ( Figure 5D and Figure S5C ). Whereas GLUT1 is known to regulate glucose uptake and proliferation of T cells (Macintyre et al., 2014) and is highly expressed in activated T cells ( Figure S4C ), the role of GLUT3 in T cells is not well defined. We found that ablation of GLUT3 expression by CRISPR/Cas9 gene editing ( Figure 5E ) impaired the TCR-induced expansion of T cells in vitro ( Figure 5F ), suggesting that like GLUT1, GLUT3 contributes to glucose uptake and proliferation of T cells. We further assessed the contribution of NFAT to the expression of glycolytic genes, glucose uptake, and antigen-dependent T cell proliferation by ectopically expressing caNFATc1 in T cells from Stim1 fl/fl Stim2 fl/fl Cd4cre mice. Expression of caNFATc1 restored the amounts of IRF4 ( Figure 5G ) and GLUT1 ( Figure 5H ) in SOCE-deficient T cells, although not completely. Because we did not observe NFAT binding to the Slc2a1 promoter, the effects of caNFATc1 on GLUT1 expression are most likely indirect. Importantly however, ectopic expression of caNFATc1 in SOCE-deficient T cells completely normalized glucose uptake ( Figure 5I ), comparable to the rescue achieved by ectopic expression of GLUT1 ( Figure S5D and S5E Figure 5J ). Transduction of SOCE-deficient T cells with either caNFATc1 or GLUT1 markedly increased the clonal expansion of LCMVspecific T cells in host mice ( Figures 5K and 5L) . A similar partial rescue was achieved by overexpression of IRF4 or c-Myc ( Figures S5F-S5G ). Collectively, these findings demonstrate that NFATc1 is a critical transcriptional regulator of glycolytic gene expression downstream of SOCE.
SOCE and Calcineurin Regulate the PI3K-AKT-mTOR Pathway in T Cells
In contrast to inhibition of SOCE or calcineurin, deletion of Nfatc1 and Nfatc2 only partially reduced glycolytic gene expression in T cells. We hypothesized that SOCE and calcineurin control glycolysis through additional, NFAT-independent pathways. The PI3K-AKT-mTOR pathway promotes aerobic glycolysis and thereby T cell growth and proliferation upon TCR and CD28 stimulation (Buck et al., 2015) . We did not observe differences in mRNA expression of PI3K-AKT-mTOR pathway-related genes in resting T cells of WT and Stim1 fl/fl Stim2 fl/fl Cd4cre mice, and we found only a moderate reduction of mRNA amounts of
Pdk1, Mtor, and the mTOR targets Mdm2 and Rps6 in stimulated SOCE-deficient T cells compared to WT T cells (data not shown).
By contrast, lack of SOCE or calcineurin activity resulted in pronounced defects in the phosphorylation of AKT (on S473 and T308), mTOR (on S2448), and S6 ribosomal protein (on S235/ 236) ( Figures 6A-6D , 2008) . The thymic development and homeostatic proliferation of T cells in the periphery is dependent on IL-7 (Akashi et al., 1998) , which has been shown to induce GLUT1 expression and glycolysis (Jacobs et al., 2010) . The addition of IL-7 ( Figure 6E ) or IL-2 ( Figure 6E and Figure S1 ) alone did not restore proliferation of SOCE-deficient T cells. However, the combination of IL-2 and IL-7 markedly enhanced the expansion of SOCE-deficient T cells in vitro ( Figure 6E ). IL-7 and IL-2 were shown to activate NFATc1 through alternative, Ca 2+ -and calcineurin-independent mechanisms in thymocytes and naive CD8 + T cells, respectively (Cho et al., 2013; Patra et al., 2013) . We therefore tested whether IL-2 and IL-7 can trigger NFAT activation in T cells from Stim1 fl/fl Stim2 fl/fl Cd4cre mice independently of SOCE and calcineurin. After stimulation with aCD3 and aCD28 antibodies, NFATc1 translocation to the nucleus was strongly impaired in SOCE-deficient T cells compared to WT T cells ( Figure 6F ). Addition of IL-2 and IL-7 markedly restored NFATc1 translocation in SOCE-deficient T cells ( Figure 6F ). TCR stimulation in the presence of both IL-2 and IL-7 (but not either cytokine alone) also rescued the expression of Slc2a1, Slc2a3, Hk2, Myc, and Irf4 in SOCE-deficient T cells ( Figure 6G and Figure S6A ). These effects of IL-2 and IL-7 were mediated at least in part through the PI3K-AKTmTOR pathway, as shown by the observation that IL-2 and IL-7 treatment partially restored phosphorylation of mTOR (on S2448) and S6 (on S235/236) in stimulated SOCE-deficient ) mice 24 hr after aCD3 and aCD28 stimulation in the presence of 1 mM FK506 alone, IL-2 and IL-7 alone, or the absence of any of these by flow cytometry; means ± SEM of 3 or 4 mice.
(legend continued on next page)
T cells ( Figure 6A-6D) . Collectively, these data demonstrate that IL-2 and IL-7 mediate non-redundant signals that promote the metabolic reprogramming of T cells independent of SOCE, thus providing an explanation for why SOCE-deficient mice and patients have normal numbers of T cells despite exhibiting defects in antigen-dependent proliferation.
The Role of SOCE in T Cell Proliferation and Metabolism Is Conserved in Humans T cells from patients with null mutations in ORAI1 or STIM1 have reduced proliferative responses after TCR stimulation with aCD3, mitogens, and microbial antigens (Lacruz and Feske, 2015) . We therefore investigated if SOCE is also required for the metabolic reprogramming of human T cells. Inhibition of SOCE with the CRAC channel inhibitor BTP2 impaired GLUT1 protein expression and inhibited glucose uptake of stimulated human T cells ( Figures S6B and S6C ). We next investigated the function and glycolysis of the peripheral T cells of a patient homozygous for a missense mutation in STIM1 (c.1121T>C; p.L374P) that abolishes SOCE ( Figure 7A ). The patient suffered from combined immunodeficiency characterized by recurrent infections and non-immunological symptoms including anhidrotic ectodermal dysplasia and myopathy that are typical of CRAC channelopathy (Lacruz and Feske, 2015) . Although the patient had normal numbers of peripheral T cells, clinical testing of the patient's peripheral blood mononuclear cells (PBMCs) showed impaired lymphocyte proliferation in response to mitogens and vaccine-derived antigens (rubella, mumps, measles, CMV, HSV, and candida) (data not shown). In addition, his CD4 + T cells failed to proliferate in response to aCD3 and aCD28 stimulation in vitro, similar to the behavior of FK506-treated T cells from a healthy donor ( Figure 7B ). The patient's T cells did not increase in size ( Figure 7C ), lacked upregulation of GLUT1 expression ( Figure 7D ), and showed reduced glucose uptake ( Figure 7E ) upon stimulation. Besides impaired induction of SLC2A1 expression, stimulated STIM1-deficient human T cells showed impaired expression of the glycolytic enzymes HK2 and PGK1 ( Figure 7F ) and the transcriptional regulators MYC, IRF4, and PPRC1 ( Figure 7G ). Taken together, these data demonstrate that SOCE and calcineurin have conserved roles in the metabolic reprogramming of mouse and human T cells.
DISCUSSION
We report here that SOCE and calcineurin control the TCRinduced proliferation of T cells through metabolic reprogramming. We identified NFAT as a critical SOCE-and calcineurinregulated transcription factor that controls expression of glucose transporters, glycolytic enzymes, and transcriptional regulators of glycolysis. In addition, SOCE and calcineurin regulate mitochondrial function and the activity of the PI3K-AKT-mTOR pathway. Calcineurin inhibition is used extensively in clinical medicine to prevent allotransplant rejection and treat certain autoimmune diseases (Azzi et al., 2013) . Despite the decadeslong use of CsA and tacrolimus, a satisfying understanding of the molecular mechanism by which calcineurin inhibition regulates T cell proliferation is missing (Azzi et al., 2013) . Two of the main explanations are that Ca 2+ and calcineurin regulate T cell proliferation by controlling IL-2 production or promoting cell-cycle progression. IL-2 was first identified as an autocrine and paracrine growth factor for T cells and has been shown to promote the differentiation of T cells into defined effector T cell subsets (Boyman and Sprent, 2012) . T cells of patients with null mutations in ORAI1 or STIM1 lack SOCE and IL-2 production upon TCR stimulation. However, addition of exogenous IL-2 has had variable effects on their ability to proliferate in vitro (Feske et al., 1996; Fuchs et al., 2012; Picard et al., 2009; Schaballie et al., 2015) . Similarly, the proliferation of murine T cells lacking STIM1 and STIM2 could not be restored by exogenous IL-2 in vitro, and they failed to proliferate in response to LCMV infection in vivo even when transferred to immunocompetent (i.e., IL-2-producing) WT host mice. Lack of IL-2 production therefore is not the primary cause of impaired proliferation of SOCE-or calcineurin-deficient T cells. NFAT was reported to promote T cell proliferation by regulating the expression and function of cell-cycle genes, including cyclins and cyclin-dependent kinases (Mognol et al., 2016) . The Ca 2+ channels promoting Ca 2+ signaling and cell-cycle progression remain ill-defined, but a recent report has implicated SOCE in the regulation of the G1/S checkpoint (Chen et al., 2016) . Our finding that SOCE-deficient and FK506-treated T cells failed to enter the cell cycle and remained in G 0 phase after TCR stimulation suggests that SOCE controls cell-cycle entry in T cells at an even earlier checkpoint.
Cell-cycle entry and clonal expansion of T cells depend on the availability of nutrients and the ability of T cells to switch from low-rate catabolism to high-rate anabolic metabolism. Quiescent T cells have minimal nutrient uptake and biosynthesis, a basal glycolytic rate, and effective oxidative phosphorylation (Buck et al., 2015; Pearce et al., 2013) . Upon encountering antigens, T cells switch to a high-rate anabolic metabolism that supports the synthesis of macromolecules required for growth and cell division. This synthesis is mainly fueled by the uptake of extracellular glucose and aerobic glycolysis. We found that this glycolytic switch was regulated by SOCE and calcineurin, which controlled the expression of the glucose transporters GLUT1 and GLUT3 and many glycolytic enzymes. Defective glucose uptake and utilization in SOCE-and calcineurin-deficient T cells resulted in a dramatic reduction of many glycolytic metabolites, including nucleotides and amino acids. Lack of adequate nutrient supply imposes cell-cycle arrest (Foster et al., 2010) , explaining why SOCE-and calcineurin-deficient T cells fail to proliferate. Consequentially, ectopic expression of GLUT1 in SOCE-deficient T cells restored T cell proliferation, albeit incompletely. SOCE and calcineurin regulated the metabolic reprogramming of T cells predominantly through NFAT. The expression of Slc2a1, Slc2a3, Hk2, and other glycolytic enzymes was abolished in SOCE-deficient and FK506-treated T cells. Likewise, deletion of NFATc1 and NFATc2 strongly attenuated the (E-G) Analysis of (E) T cell proliferation by CFSE dilution, (F) NFATc1 nuclear translocation by confocal microscopy, and (G) glycolytic gene expression by qRT-PCR (means ± SEM of 3 or 4 mice) of WT and Stim1/2 CD4 CD4 + T cells 3 days after aCD3 and aCD28 stimulation in the presence or absence of IL-2, IL-7, or both.
Data in (A-E) are representative of 2 or 3 repeat experiments. Percentages of NFATc1 localization in (F) are means ± SEM of >100 cells from three repeat experiments. See also Figure S6 .
expression of these genes. Expression of a constitutively active form of NFATc1, on the other hand, enhanced transcription of all four genes, demonstrating that NFAT is a critical regulator of glycolytic gene expression in T cells. This regulation is both direct (through NFAT binding to promoter and enhancer elements of glycolysis genes) and indirect (through NFAT-dependent expression of transcription factors, such as c-Myc , IRF4 [Man et al., 2013] , and HIF-1a , that function as regulators of glycolytic metabolism). Although we found NFAT binding motifs in the regulatory elements of most SOCE-regulated glycolytic genes, evidence of robust NFAT binding from ChIP-Seq data was restricted to Irf4, Hif1a, Hk2, and Slc2a3. NFATc1 and NFATc2 bound to the promoter and an enhancer region that was À16 kb distal of Slc2a3, and GLUT3 expression was strongly reduced in T cells from Nfatc1 fl/fl Nfatc2 -/-Cd4cre mice. Conversely, the expression of Slc2a3 was increased in T cells of transgenic mice expressing caNFATc1. Together with the observation that deletion of Slc2a3 expression impairs T cell proliferation, these findings suggest that GLUT3 is a directly NFAT-regulated glucose transporter that promotes glycolysis and T cell proliferation in murine T cells. SOCE and calcineurin furthermore regulated the metabolic reprogramming of T cells indirectly by controlling the expression of transcriptional regulators of glycolysis. TCR stimulation resulted in the SOCE-dependent induction of Myc, Hif1a, and Irf4 within a few hours preceding the expression of Slc2a1, Slc2a3, and glycolytic enzymes, which suggested that SOCE might regulate the glycolytic switch of T cells indirectly. c-Myc broadly induces expression of glycolytic and glutaminolytic enzymes as well as regulators of lipid, amino acid, and nucleotide synthesis . Similarly, IRF4 and HIF-1a were shown to promote expression of genes regulating metabolism, glycolysis in particular (Man et al., 2013; Shi et al., 2011; Wang et al., 2011) . NFATc1 and NFATc2 bind to the promoters of Irf4 and Hif1a, and the expression of HIF-1a and IRF4 was strongly reduced in T cells of Nfatc1 fl/fl Nfatc2 -/-Cd4cre mice, but increased in T cells expressing caNFATc1. By contrast, we did not find evidence of direct regulation of Myc by NFAT in T cells despite previous reports of NFAT binding to the Myc promoter in various cell types (Mognol et al., 2016 ) and a recent study suggesting that NFAT induces transcription of Myc in T cells (Mak et al., 2017) . GLUT1, although expressed in a SOCE-dependent manner, appears to be an indirect NFAT target as no direct NFAT binding to regulatory elements in Slc2a1 was detected. Collectively, our data demonstrate that SOCE and calcineurin control the glycolytic reprogramming of T cells directly and indirectly through NFATregulated expression of glucose transporters, glycolytic enzymes, and transcriptional regulators of glycolysis.
SOCE and calcineurin also regulated other aspects of T cell metabolism, which helps explain why expression of caNFATc1 in SOCE-deficient T cells only partially restored proliferation. First, we found that the activity of the PI3K-AKT-mTOR pathway is impaired in SOCE-deficient T cells after TCR stimulation, as evidenced by the fact that phosphorylation of AKT, mTOR, and the ribosomal S6 protein was strongly reduced. Activation of the PI3K-AKT-mTOR pathway by SOCE is consistent with recent reports of AKT regulation by the Ca 2+ -and calmodulin-dependent protein kinase IV (CaMK4) in T helper-17 (Th17) cells (Koga et al., 2014) and mTORC1 activation by lysosomal Ca 2+ release and CaM binding in non-immune cells (Li et al., 2016) . In addition, inhibition of calcineurin was reported to block phosphorylation of the mTOR target S6 (Mak et al., 2017) . The mechanisms underlying the crosstalk between the SOCE-calcineurin and PI3K-AKTmTOR pathways in T cells remain to be elucidated. Second, the role of SOCE and calcineurin in T cell metabolism was not limited to glycolysis but also included mitochondrial function. SOCE-deficient T cells failed to increase mitochondrial size; expression of ETC complexes I, II, or IV; mitochondrial respiration; and ATP production upon TCR stimulation. These defects were associated with decreased expression of PPRC1, suggesting that SOCE might control mitochondrial biogenesis at the transcriptional level. Impaired mitochondrial function of SOCE-deficient T cells is consistent with similar findings in fibroblasts (Maus et al., 2017) T cells, suggesting that the development and homeostatic proliferation of T cells is independent of SOCE. T cell development in the thymus and the survival of naive and memory T cells require IL-7, which was shown to induce GLUT1 expression and glycolysis in T cells (Jacobs et al., 2010) . We found that IL-7, together with IL-2, can restore the TCR-induced proliferation of SOCEdeficient T cells. This rescue was associated with the increased expression of glucose transporters, glycolytic enzymes, and metabolic regulators as well as partially restored mTOR activity. IL-7 was shown to activate NFATc1 through an alternative, Ca 2+ -and calcineurin-independent mechanism in thymocytes (Patra et al., 2013) ; this mechanism is similar to IL-2-mediated activation of NFATc1 in naive CD8 + T cells (Cho et al., 2013) . Indeed, we observed nuclear translocation of NFATc1 in stimulated SOCE-deficient T cells in the presence of IL-2 and IL-7, demonstrating that both cytokines synergize to promote NFAT activation, glycolysis, and proliferation of T cells independently of SOCE. Although SOCE is essential for TCR-induced proliferation, cytokine-mediated (homeostatic) expansion of T cells is possible in its absence and probably explains why SOCE-deficient mice and humans have normal overall T cell numbers but reduced numbers of antigen-specific T cells (Lacruz and Feske, 2015; Vaeth et al., 2016) . The mechanisms by which SOCE and calcineurin regulate the glycolytic reprogramming of TCR-stimulated T cells are conserved in humans. SOCE-deficient T cells of an immunodeficient patient with a null mutation in STIM1 failed to upregulate GLUT1, HK2, c-Myc, or IRF4 expression, resulting in reduced glucose uptake. These defects probably explain impaired T cell proliferation of SOCE-deficient patients and contribute to their immunodeficiency. Our study reveals essential molecular mechanisms by which SOCE, calcineurin, and NFAT control T cell function and explains why calcineurin inhibitors are potent immunosuppressants in organ transplantation, graft-versus-host disease, and certain forms of autoimmunity.
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M.V., M.M., S.K.-H., E.F., J.Y., M.E., E.S., F.F.-S., R.P., and S.F. conducted experiments, analyzed data, and interpreted the results. S.E.T. and S.C. provided patient material and obtained clinical data. M.M., M.V., and S.F. designed the study and wrote the manuscript. of 1 mM FK506 (Sigma Aldrich), 10 mM 2-DG (Sigma Aldrich), 5 ng/ml IL-7 (Peprotech), 50 U/ml IL-2 (Peprotech) or left unstimulated as indicated. PBMCs from individuals homozygous (patient) and heterozygous (mother) for a STIM1 p.L374P mutation were isolated from blood samples by density centrifugation using Ficoll-Paque plus (GE Amersham). Human CD4 + T cells were isolated using CD4
MicroBeads (Miltenyi Biotec). PBMCs or purified T cells were stimulated with 5 mg/ml plate-bound anti-CD3 (clone OKT3) and 10 mg/ml soluble anti-CD28 (clone CD28.2, both eBioscience) monoclonal antibodies in the presence or absence of 1 mM FK506 (Sigma Aldrich) or 500 nM BTP2 (Sigma Aldrich) or left unstimulated as indicated.
Reporter gene assays
The murine Slc2a3 promoter (À475/+358) was amplified from genomic DNA using the primers 5 0 -AAAAGCTTGAAATGT GCCTGCCTCCTGC-3 0 and 5 0 -TTGTCCCCATGGTCCCAACC-3 0 and cloned as a HindIII/NcoI fragment matching Slc2a3-ATG with luciferase ATG into the pGL3-Basic backbone (Invitrogen). The À16 kb distal enhancer region of the Slc2a3 gene was amplified by PCR using the primers 5 0 -AAAAGCTTGAAATGTGCCTGCCTCCTGC-3 0 and 5 0 -TTGTCCCCATGGTCCCAACC-3 0 and cloned as a 916 bp NheI/XhoI fragment upstream of the promoter. HEK293T cell reporter gene assays were performed as described .
Vectors encoding constitutively active NFATc1 (MIGR-caNFATc1-IRES-GFP) (Gomez-Rodriguez et al., 2009 ) and GLUT1 (Slc2a1, pMIGR-Slc2a1-IRES-VEX) were kindly provided by P. Schwartzberg (NIH Human Genome Research Institute, Bethesda, MD) and J. Wherry (University of Pennsylvania, Philadelphia, PA), respectively. 20 bp oligonucleotides targeting exon 1 of the Slc2a3 gene (5 0 -GGGCGTTCTTCAATGCCACG-3 0 , 5 0 -CATTGTGTGGAGTTTTGCCG-3 0 , 5 0 -TGTGTTGTAGCCAAACTGCA-3 0 ) were cloned into a retroviral vector for guide RNA delivery, which was a kind gift from M. Aichinger and J. Zuber (Vienna Biocenter, Austria). Expression vectors for IRF4 (pMIG-IRF4, #58987) c-Myc (pMIG-Myc, #58987) were obtained from Addgene. anti-CD4 (clone GK1.5), anti-CD8 (53-6.7), anti-TCR Va2 (B20.1), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-Ki-67 (SolA15) antibodies were from eBioscience. Mitochondrial complexes were detected with the Total Oxphos Rodent WB antibody cocktail (MitoSciences) and an HRP-conjugated anti-mouse secondary antibody (Sigma Aldrich). GLUT1 protein expression was detected with a polyclonal anti-GLUT1 antibody (Abcam, ab115730) and an Alexa-647 conjugated goat-anti-rabbit-IgG secondary antibody (Molecular Probes). GLUT3 expression was analyzed using a polyclonal, FITC-conjugated anti-mouse-GLUT3 antibody (Abcam, ab136180). For analysis of phosphorylated AKT, mTOR and ribosomal S6 protein, total T cells were stimulated for 24 hr with anti-CD3/CD28 with or without 1 mM FK506 and immediately fixed with IC fixation buffer (eBioscience). Protein phosphorylation was detected in permeabilized CD4 + and CD8 + T cells using anti-phospho-AKT Thr308 (D25E6, Cell Signaling Technology), anti-phospho-AKT Ser473
(SDRNR), anti-phospho-mTOR Ser2448 (MRRBY) and anti-phospho-S6 Ser235/236 (cupk43k, all eBioscience). Unconjugated rabbit anti-phospho-AKT Thr308 primary antibody was detected using an AlexaFlour-647-conjugated goat-anti-rabbit IgG secondary antibody (Molecular probes).
Retroviral transduction and adoptive transfer of SMARTA CD4 + T cells CD4 + T cells were isolated using a mouse CD4 T Cell Enrichment kit (STEMCELL Technologies) and stimulated with 1 mg/ml platebound anti-CD3 (clone 2C11) plus 1 mg/ml anti-CD28 Abs (clone 37.51, both BioXCess) in the presence of 50 U/ml IL-2 (Peprotech) and 2.5 ng/ml IL-7 (Peprotech). T cells were transduced 24 hr after stimulation by spin-infection (2.500 rpm, 30 C, 90 min) in the presence of concentrated retroviral supernatant and 10 mg/ml polybrene (SantaCruz). Retroviral supernatant was produced in the Platinum-E retroviral packaging cell line. Platinum-E cells were transfected by lipofection (GeneJet, Fisher) with retroviral expression plasmids and the amphotrophic packaging vector pCL-10A1. Two days after transfection, the supernatant was collected and concentrated using Amicon Ultra-15 centrifugal filters (Merck Millipore). 4 hr after spin-infection, viral supernatant was removed from the T cells and replaced by fresh media. 48 hr after transduction, T cells were transferred into new plates adding fresh media containing 50 U/ml IL-2 and 2.5 ng/ml IL-7 and rested for 2 days in IL-2 and IL-7 containing medium. Transduced cells (GFP + ) were FACS-sorted using a sterile Sony SY3200 (HAPS1) cell sorter and 4x10 5 GFP + CD45.1 + SMARTA CD4 + T cells were retro-orbitally injected into recipient CD45.2 + host mice. 3 days after adoptive transfer, host mice were infected i.p. with 2x10 5 PFU LCMV (Armstrong strain) and expansion of CD45.1 + Va2 TCR + donor T cells in the spleen was analyzed 8-10 days later by flow cytometry as described (Vaeth et al., 2016) .
Flow cytometry
Cells were washed in ice-cold PBS containing 1% FBS before blocking with anti-FcgRII/FcgRIII antibodies (2.4G2, eBioscience). Staining of surface molecules with fluorescently labeled antibodies was performed at room temperature for 20 min in the dark. GLUT1 or GLUT3 expression was detected in cells fixed and permeabilized with the IC Staining Buffer Kit (BioLegend) using a polyclonal rabbit anti-GLUT1 antibody (Abcam, ab115730) together with an Alexa-647 conjugated anti-rabbit IgG secondary antibody (Molecular Probes) or a polyclonal, FITC-conjugated anti-GLUT3 antibody (Abcam, ab136180). Samples were acquired on a LSRII flow cytometer using FACSDiva software (BD Biosciences) and further analyzed with FlowJo software (Tree Star).
CFSE dilution assay CD4 + and total T cells were loaded with 2.5 mM CFSE (Molecular Probes) according to the manufacturer's instructions and stimulated with anti-CD3 and anti-CD28 antibodies in the presence or absence of 1 mM FK506, 50 U/ml IL-2, 5 ng/ml IL-7, a combination of IL-2 and IL-7 or left unstimulated as indicated. 72 to 96 hr after stimulation, CFSE dilution was assessed by flow cytometry.
Extracellular flux analysis
Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were measured using an XF e 24 Extracellular Flux Analyzer (Seahorse Bioscience). Before experiments, cells were resuspended in XF media (Seahorse Biosciences) supplemented with 10 mM glucose (Sigma Aldrich), 1 mM GlutaMAX (GIBCO) and 1 mM sodium pyruvate (Corning) and analyzed under basal conditions and following treatment with the following agents: the ATP synthase inhibitor oligomycin (1 mM); the protonophore Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) (0.75 mM) to uncouple mitochondria; the mitochondrial complex I inhibitor rotenone (100 nM) and the mitochondrial complex III inhibitor antimycin A (1 mM). The basal oxygen consumption rate (OCR) was calculated by subtracting the OCR after rotenone and antimycin A treatment from the OCR before oligomycin treatment. The maximal OCR was calculated by subtracting the OCR after rotenone and antimycin A treatment from the OCR measured after addition of FCCP.
Metabolite Profiling LC/MS analyses were conducted on a QExactive benchtop orbitrap mass spectrometer equipped with an Ion Max source and a HESI II probe, which was coupled to a Dionex UltiMate 3000 UPLC system (Thermo Fisher Scientific, San Jose, CA). External mass calibration was performed using the standard calibration mixture every 7 days. For metabolite profiling experiments, CD4 + T cells were stimulated with plate bound anti-CD3 and anti-CD28 for 36 hr. Cells were collected and cell pellets were washed with ice cold PBS. Polar metabolites were extracted using 1 mL of ice-cold 80% methanol with 10 ng/ml valine-d 8 as an internal standard. After a 10 min vortex and centrifugation for 10 min at 4 C at 10,000 g, samples were dried in a table-top vacuum centrifuge. Dried samples were stored at À80 C and then resuspended in 100 mL water; 1 mL of each sample was injected onto a ZIC-pHILIC 2.1 3 150 mm (5 mm particle size) column (EMD Millipore). Buffer A was 20 mM ammonium carbonate, 0.1% ammonium hydroxide; buffer B was acetonitrile. The chromatographic gradient was run at a flow rate of 0.150 ml/min as follows: 0-20 min.: linear gradient from 80% to 20% B; 20-20.5 min.: linear gradient from 20% to 80% B; 20.5-28 min.: hold at 80% B. The mass spectrometer was operated in full-scan, polarity switching mode with the spray voltage set to 3.0 kV, the heated capillary held at 275 C, and the HESI probe held at 350 C. The sheath gas flow was set to 40 units, the auxiliary gas flow was set to 15 units, and the sweep gas flow was set to 1 unit. The MS data acquisition was performed in a range of 70-1000 m/z, with the resolution set at 70,000, the AGC target at 10 6 , and the Intracellular Ca 2+ measurement Isolated human CD4 + T cells were bound to poly-L-Lysine (Sigma Aldrich) coated translucent 96-well plates (BD Falcon). Cells were loaded with 1 mM Fura-2-AM (Molecular Probes), and washed twice with 0 mM Ca 2+ Ringer solution as described Vaeth et al., 2017) . Ca 2+ measurements were performed using a FlexStation 3 multi-mode microplate reader (Molecular Devices). Cells were resuspended in 0 mM Ca 2+ Ringer solution at the beginning of measurements. After 120 s, 1 mM thapsigargin (Calbiochem) was added to induce activate CRAC channels by depleting ER Ca 2+ stores. At 420 s, 2 mM Ca 2+ containing Ringer solution was added to the cells (to obtain a 1 mM final extracellular Ca 2+ concentration) to measure SOCE. Fura-2 fluorescence was measured at 510 nm after excitation at 340 nm and 380 nm and plotted as the F340/F380 emission ratio.
Real-time PCR Total RNA was isolated using Trizol (Invitrogen) or the RNeasy Micro Kit (Quiagen) and cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad). Quantitative realtime PCR was performed using the Maxima SYBR Green qPCR Master Mix (Thermo) and gene specific primers (Table S1 ). The relative abundance of transcripts was normalized to the expression of housekeeping genes using the 2 -DCT method. Relative expression values were calculated by normalizing gene expression to the average of untreated WT or healthy donor controls.
Immunoblotting
Total cell lysates were prepared in lysis buffer containing 1% Triton X-100, 50 mM HEPES (pH 7.4), 250 mM NaCl, 10 mM EDTA, 2 mM sodium-o-vanadate, 10 mM sodium pyrophosphate, 10% glycerol, 10 mg/ml aprotinin, 10 mg/ml pepstatin, 5 mg/ml leupeptin and 0.2 mM PMSF. Lysates from equal numbers of cells for each condition were subjected to SDS-PAGE, transferred to nitrocellulose membrane, blocked with low-fat milk and incubated with the Total Oxphos Rodent WB antibody cocktail (MitoSciences) overnight. Proteins were visualized using an HPR-conjugated anti-mouse secondary antibody (Sigma) and chemiluminescent ECL reagent (Thermo Fisher). Densitometric quantification was performed using ImageJ.
Analysis of NFATc1 and NFATc2 ChIP-seq data NFATc2 ChIP-seq data (Martinez et al., 2015) and genome-wide NFATc1 chromatin binding data (using T cells from a BAC-transgenic mouse strain in which NFATc1 is endogenously biotinylated by the biotin-ligase BirA and precipitated using streptavidin beads) (Klein-Hessling et al., 2017) were aligned to open chromatin regions defined by DNase I hypersensitivity sites in naive and CD8 + T cell blasts (Bevington et al., 2016) and accessible chromatin regions defined by ATAC-seq in resting and PMA/ionomycin-stimulated CD8 + T cells (Mognol et al., 2017) . All sequencing data was mapped to the mouse mm9 genome assembly using the Bowtie software package. NFATc1 and NFATc2 binding peaks were identified using the model-based analysis of ChIPseq (MACS) method and are indicated in figures by asterisks.
QUANTIFICATION AND STATISTICAL ANALYSIS
All numerical results are mean ± standard error of the means (SEM). The statistical significance of differences between experimental groups was determined by Student's t test. Multiple comparisons were performed using normalization to the averages of control values. Differences were considered significant for p values < 0.05 (noted in figures as *), p < 0.01 (**) and p < 0.001 (***). The number of repeat experiments and mice per group are indicated in the respective figure legends.
DATA AND SOFTWARE AVAILABILITY
GEO accession numbers for NFATc1 ChIP-seq data (GSE98726), NFATc2 ChIP-seq data (GSE64409), DNase I hypersensitivity data (GSE67451) and ATAC-seq data (GSE88987).
